FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

Drugs

Lifyorli (relacorilant) · Glucocorticoid receptor antagonist, nab-paclitaxel

Condition

Gynecologic